www.bestgenerics.net
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Ezetimibe - Vytorin, Zetia
Generic Vytorin
Simvastatin Ezetimibe 10mg + 10/20mg + 10mg
Generic Vytorin is used for treating high cholesterol along with a cholesterol-lowering diet. It works by reducing the amount of cholesterol that your body absorbs from your meals. Lowering cholesterol levels in the blood reduces the chance of heart disease, heart attacks and strokes.
$1.97
Buy now!
Generic Zetia
Generic Zetia is used for treating high blood cholesterol along with a low-fat, low-cholesterol diet. It may be used alone or with other medicines. It is also used to treat high blood sitosterol and campesterol along with diet therapy.
$1.17
Buy now!
Choose Your language:
- Testimonials
-
Thank you very much, I recieved the 4 pills of cialis offered , plus some extra cialis and viagra. It has been a pleasure to deal with you. - Best wishes Mario
Read more »
-
- Merck Wins U.S. ZETIA(R) (ezetimibe)/ VYTORIN(R) (ezetimibe/simvastatin ... - MarketWatch (press release)
- Merck Wins U
- Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks; - FiercePharma
- Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks;FiercePharmaArticle | Follow @FiercePharma > A US court upheld Merck's ($MRK) patent on the active ingredient ezetimibe, marketed as the cholesterol-lowering Zetia and in the combo cholesterol pill Vytorin
- Investor Medical Waves - (VVUS, MRK, MYL, AMPE) - Galaxy Stocks
- Investor Medical Waves - (VVUS, MRK, MYL, AMPE)Galaxy StocksInc
- Advanced Atherosclerosis: The Heart and Beyond - Medscape
- Advanced Atherosclerosis: The Heart and BeyondMedscapeThe premise of AIM-HIGH was to see if adding extended-release niacin to raise HDL cholesterol in patients who had already achieved a very low LDL cholesterol level (40 to 80 mg/dL) with simvastatin (and ezetimibe if needed) would lead to further risk
- Toward Regenerative Medicine Against Atherosclerosis cardiovascular disease - Next Big Future
- Toward Regenerative Medicine Against Atherosclerosis cardiovascular diseaseNext Big FutureOnce-promizing agents such as ezetimibe, niacin, ApoA-1 Milano, and torcetrapib have either been found to provide no benefit, or evento increase mortality rates
 |
Subscribe to the News |
|---|
